Screener
Prime Medicine PRME CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows provided by (used in) investing activities: | ||
| Maturities of investments | 93,953 | 14,250 |
| Purchases of investments | (26,272) | (55,227) |
| Purchases of property and equipment | (260) | (3,994) |
| Net cash provided by (used in) investing activities | 67,421 | (44,971) |
| Cash flows provided by financing activities: | ||
| Net proceeds from stock option exercises | 416 | — |
| Proceeds from ESPP offerings | 338 | 197 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's capex?
- Prime Medicine (PRME) reported capex of $46K in Q2 2026.
- How has Prime Medicine's capex changed year-over-year?
- Prime Medicine's capex decreased by 97.1% year-over-year, from $1.57M to $46K.
- What is the long-term trend for Prime Medicine's capex?
- Over 3 years (2022 to 2025), Prime Medicine's capex has grown at a -34.5% compound annual growth rate (CAGR), from $16.1M to $4.53M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Prime Medicine's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude